Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AMG 820 |
Synonyms | |
Therapy Description |
AMG 820 is a monoclonal antibody that binds CSF1R and prevents ligand binding, potentially resulting in decreased growth of CSF1-driven tumor cells (Cancer Res May 1, 2009 69; 2077, PMID: 28655795). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMG 820 | CSF1R Antibody 5 | AMG 820 is a monoclonal antibody that binds CSF1R and prevents ligand binding, potentially resulting in decreased growth of CSF1-driven tumor cells (Cancer Res May 1, 2009 69; 2077, PMID: 28655795). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04938180 | Phase II | AMG 820 | A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients | Terminated | POL | HUN | 1 |